Could a common ED drug help scleroderma patients breathe easier?
NCT ID NCT04797286
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This study tests whether sildenafil, a drug that relaxes blood vessels, can improve walking distance and heart function in 30 people with scleroderma who have mildly high blood pressure in their lungs. Participants will receive either sildenafil or a placebo for up to 12 months. The goal is to see if the drug can slow or improve early lung and heart changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Louisiana State University
NOT_YET_RECRUITINGNew Orleans, Louisiana, 70806, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.